Expert NetworkExpert InterviewSNY

Slingshot members are talking to an expert! The topic is:

Discussing the potential use of Sanofi and AstraZeneca’s newly approved RSV antibody drug for infants, nirsevimab, with a Pediatric Allergist

Executed on:Jul 19, 2023 6:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Deaconess Clinic
  • Allergist and immunologist in practice since 2001
  • treats 13 patients/year with HAE
  • Familiar with Donidalorsen and has prescribed Haegarda, Orladeyo, and Takhzyro for patients with HAE

Interview Goal

This interview will focus on the recent FDA approval of Nirsevimab as an RSV preventative option for the broad newborn and infant population.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.